Ependymoma
📧 Sign up to get email alerts when something new happens for Ependymoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma [Phase 2]
The Phase 2 trial evaluating carboplatin as a radiosensitizer for childhood ependymoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia [Phase 1]
Phase 1 study of RO4929097, a gamma-secretase inhibitor, in pediatric patients with relapsed or refractory solid tumors, CNS tumors, lymphom…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma [Phase 2]
Phase 2 trial comparing erlotinib to oral etoposide in pediatric ependymoma was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors [Phase 1]
This Phase 1 trial evaluates the combination of temozolomide and O6-benzylguanine in pediatric patients with recurrent brain tumors.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors [Phase 1]
A Phase 1 clinical trial evaluated lenalidomide in young patients with recurrent, progressive, or refractory central nervous system tumors. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Cilengitide in Treating Children With Refractory Primary Brain Tumors [Phase 1]
Phase 1 trial of cilengitide in children with refractory primary brain tumors has completed; the study explored safety, dosing, and tolerabi…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma [Phase 2]
A Phase 2 clinical trial evaluating high-dose methotrexate in young patients with residual ependymoma is described (status not reported).
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma [Phase 2]
This is a Phase 2 trial update for treating localized ependymoma in children with combination chemotherapy followed by radiation therapy. Th…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Etoposide in Treating Young Patients With Relapsed Ependymoma [Phase 2]
This clinical trial update describes a Phase 2 study of etoposide for relapsed ependymoma in young patients. The current trial status is lis…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma [Phase 2]
Phase 2 study of combination chemotherapy followed by radiation therapy in children with medulloblastoma, supratentorial primitive neuroecto…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [Phase 1]
A Phase 1 study of flavopiridol in children with relapsed or refractory solid tumors or lymphomas has completed, focusing on safety and dosi…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab to reduce central nervous system side effects after brain radiotherapy in patients with various brain t…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Irinotecan in Treating Children With Refractory Solid Tumors [Phase 2]
A Phase 2 trial evaluating irinotecan in children with refractory solid tumors has completed, with results reported by the Children's Oncolo…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of erlotinib and temozolomide in pediatric patients with recurrent or refractory solid tumors has c…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors [Phase 1]
Phase 1 evaluation of vorinostat in combination with temozolomide in children with relapsed or refractory primary brain tumors or spinal cor…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia [Phase 1]
Phase 1 trial evaluating FR901228 in pediatric patients with refractory or recurrent solid tumors or leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors [Phase 1]
This document is a terminated Phase 1 trial update evaluating PET imaging with 18F-EF5 to measure oxygenation in brain tumor cells of adults…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma [Phase 2]
Phase 2 trial evaluating bevacizumab combined with irinotecan in pediatric patients with recurrent or progressive brain tumors including gli…
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors [Phase 3]
Phase 3 clinical trial comparing SCRT to conventional radiotherapy in children and young adults with low-grade gliomas and benign brain tumo…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors [Phase 1, Phase 2]
This clinical trial update summarizes the results of a Phase 1/2 study evaluating lapatinib in pediatric patients with recurrent or refracto…
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas [Phase 2]
Phase 2 trial evaluating etoposide plus cisplatin in recurrent ependymoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: A Study of Pemetrexed in Children With Recurrent Cancer [Phase 2]
Pemetrexed was studied in a Phase 2 trial in children with recurrent cancer across several pediatric tumor types, including osteosarcoma and…